Institut Català de Oncologia (ICO), Hospital Dr Trueta

Girona 17007

0 studies enrolling now · 1 studies all time

What they study most

DLBCL Transformed From Indolent Lymphoma, Diffuse Large B-cell Lymphoma, Follicular Grade 3 Lymphoma, de Novo DLBCL

Studies at this site

• Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant — Completed